HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonel Torres Selected Research

Nuclear Antigens (Extractable Nuclear Antigens)

1/2023Chronic viral coinfections differentially affect the likelihood of developing long COVID.
7/2022Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leonel Torres Research Topics

Disease

6Infections
10/2022 - 01/2021
6COVID-19
07/2022 - 10/2020
3Viremia
01/2023 - 01/2022
2Fatigue
01/2023 - 07/2022
2Neoplasms (Cancer)
01/2023 - 03/2003
2Fever (Fevers)
07/2021 - 03/2021
2Cough
07/2021 - 03/2021
1Connective Tissue Diseases (Connective Tissue Disease)
08/2021
1Lung Diseases (Lung Disease)
03/2021
1Neurologic Manifestations (Neurological Manifestations)
01/2021
1Neuroinflammatory Diseases
01/2021
1Glioma (Gliomas)
03/2008

Drug/Important Bio-Agent (IBA)

4Immunoglobulin G (IgG)IBA
01/2023 - 10/2020
2AntigensIBA
01/2023 - 07/2022
2Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2023 - 07/2022
2Nucleic AcidsIBA
10/2022 - 03/2021
2RNA (Ribonucleic Acid)IBA
02/2022 - 03/2021
2Oxygen (Dioxygen)IBA
07/2021 - 03/2021
1Broadly Neutralizing AntibodiesIBA
01/2022
1Peptides (Polypeptides)IBA
10/2021
1InterferonsIBA
10/2021
1Messenger RNA (mRNA)IBA
08/2021
1COVID-19 VaccinesIBA
08/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1NeurograninIBA
01/2021
1CytokinesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Amyloid beta-PeptidesIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1AntibodiesIBA
10/2020
1EnzymesIBA
10/2020
1Immunoglobulin M (IgM)IBA
10/2020
1ImmunosorbentsIBA
10/2020
1Immunoconjugates (Immunoconjugate)IBA
03/2008
1nimotuzumabIBA
03/2008
1Monoclonal AntibodiesIBA
03/2003
1ErbB Receptors (EGF Receptor)IBA
03/2003

Therapy/Procedure

1Immunotherapy
01/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021
1Critical Care (Surgical Intensive Care)
03/2021
1Radioimmunotherapy
03/2008
1Intravenous Infusions
03/2003